Inspire Medical Systems, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Jason P Kelly, See Remarks of Inspire Medical Systems, Inc., sold 963 shares of common stock on August 7, 2026 for $59.55 per share.
NYSE
Melissa Mann, Chief People Officer of Inspire Medical Systems, Inc., reported multiple transactions in common stock on July 31, 2025.
NYSE
Michael H Carrel, a Director of Inspire Medical Systems, Inc., received 5,631 shares of common stock on July 20, 2026.
NYSE
Georgia Melenikiotou, a Director of Inspire Medical Systems, Inc., received 344 shares of common stock on July 15, 2026.
NYSE
Casey M Tansey, a Director of Inspire Medical Systems, Inc., received 346 shares of common stock on July 15, 2026.
NYSE
Gary Lee Ellis, a Director of Inspire Medical Systems, Inc., received 581 shares of common stock on July 15, 2026.
NYSE
Shelley G Broader, a Director of Inspire Medical Systems, Inc., received 383 shares of common stock on July 15, 2026.
NYSE
Chief Product and Innovation Officer John Rondoni sold 700 shares of Inspire Medical Systems common stock.
NYSE
Director Shawn McCormick reported a sale of Inspire Medical Systems Inc. common stock valued at approximately $31,550, executed under a pre-arranged trading plan.
NYSE
Director Gary Lee Ellis was granted 3,562 restricted stock units by Inspire Medical Systems, Inc. on April 30, 2026.
NYSE
Director Dana G. Mead Jr. was granted 3,562 restricted stock units (RSUs) by Inspire Medical Systems, Inc. on April 30, 2026.
NYSE
Director Casey M. Tansey was granted 3,562 restricted stock units as part of an equity compensation award.
NYSE
Director Myriam Curet was granted 3,562 restricted stock units in Inspire Medical Systems, Inc. as part of an equity award.
NYSE
Inspire Medical Systems director Cynthia Burks was granted 3,562 restricted stock units as part of an equity compensation award.
NYSE
Director Shelley G. Broader was granted 3,562 restricted stock units by Inspire Medical Systems, Inc.
NYSE
Director Shawn McCormick was granted 3,562 restricted stock units in Inspire Medical Systems, Inc. as part of an equity incentive award.
NYSE
Director Georgia Melenikiotou acquired 3,562 restricted stock units and disposed of 50 shares for tax obligations.
NYSE
Director Shelley G. Broader acquired 342 shares of Inspire Medical Systems, Inc. common stock in lieu of cash director fees.
NYSE
Inspire Medical Systems director Georgia Melenikiotou acquired 307 shares of common stock in lieu of cash director fees.
NYSE
Director Gary Lee Ellis acquired 518 shares of Inspire Medical Systems, Inc. common stock in lieu of cash director fees.
NYSE
Director Casey M. Tansey acquired 308 shares of Inspire Medical Systems, Inc. common stock in lieu of cash director fees.
NYSE
Inspire Medical Systems CEO Timothy P. Herbert received significant equity awards, increasing his direct beneficial ownership.
NYSE
Inspire Medical Systems' Senior VP Bryan K. Phillips reported significant equity awards, including performance stock units and restricted stock units, alongside tax-related share withholdings, effective February 20, 2026.
NYSE
Inspire Medical Systems' Chief Manufacturing and Quality Officer, Jason P. Kelly, was granted 15,958 restricted stock units vesting over three years.
NYSE
Inspire Medical Systems' Chief People Officer, Melissa Mann, was granted 15,958 Restricted Stock Units, vesting over three years starting February 2027.
NYSE
Carlton Weatherby, Chief Strategy and Growth Officer at Inspire Medical Systems, reported significant equity transactions including RSU grants and performance share vesting.
NYSE
Inspire Medical Systems' Chief Product and Innovation Officer, John Rondoni, reported significant equity awards, including performance-based shares and restricted stock units.
NYSE
Carlton Weatherby, Chief Strategy and Growth Officer at Inspire Medical Systems, reported a tax-related disposition of 327 common shares.
NYSE
Inspire Medical Systems' Senior VP Bryan K Phillips disposed of 327 common shares to cover tax liabilities related to a performance stock unit award.
NYSE
Inspire Medical Systems CEO Timothy P. Herbert reported a disposition of 968 shares of common stock to cover tax obligations related to a performance stock unit award.